1.5 T与3 T MRI动态对比增强对临床显著前列腺癌检出的影响
本研究回顾性分析PI-RADS 4患者中,DCE阳性使病灶升级后检出的前列腺癌在1.5 T与3 T间的差异。结果显示总体癌检出率无显著差异,但1.5 T升级的外周带病灶中癌检出率及ISUP 2-5级癌比例显著高于3 T,提示1.5 T下DCE增益更大但过度诊断风险也更高。
要点
- PI-RADS 4病灶中,DCE阳性升级后1.5 T检出更多外周带临床显著癌。
- 1.5 T升级外周带病灶中ISUP 2-5级癌比例显著高于3 T。
- 两场强总体癌检出率及升级病灶比例无显著差异。
核心结论
- DCE在1.5 T前列腺mpMRI中能检出相当数量额外的临床显著前列腺癌。
- 该效应在3 T较小,且1.5 T下伴随因检出额外低危癌而增加的过度诊断风险。
研究设计与样本
- 回顾性双中心队列研究,纳入连续PI-RADS 4且经MRI/US融合穿刺证实前列腺癌的患者。
- 1.5 T组152例,3 T组141例,每组各含100例经证实的前列腺癌。
诊断标准与关键数值
- 以DCE阳性将索引病灶升级为PI-RADS 4,比较1.5 T与3 T的癌检出。
- 总体癌检出率66% vs 71%(p=0.346),升级病灶比例28% vs 21%(p=0.126),均无显著差异。
- 1.5 T升级外周带病灶癌检出率23% vs 3 T 14%(p=0.048)。
- 1.5 T升级外周带病灶中ISUP 2-5级癌比例13.8% vs 3 T 4.0%(p=0.007)。
临床应用与阅片要点
- 阅读PI-RADS 4病灶时,需结合场强评估DCE升级的额外癌检出及过度诊断可能。
- 1.5 T下DCE阳性升级的外周带病灶应更警惕临床显著癌。
局限性
- 回顾性设计,仅纳入PI-RADS 4且穿刺证实癌的患者,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: This study analyzes the value of dynamic contrast-enhanced MRI (DCE) of the prostate on 1.5 T and 3 T examinations in patients within PI-RADS category 4.
METHODS: In this retrospective, bi-centric, cohort study all consecutive patients classified as PI-RADS 4 in mpMRI with 100 verified prostate cancers (PCa) in subsequent MRI/US-guided fusion biopsy were included for 1.5 T and 3 T, each. PCa detection in index lesions (IL) upgraded to PI-RADS 4 based on positive DCE findings was compared between 1.5 T and 3 T. Secondary objectives are subgroup analysis of PZ lesions and comparison of ISUP grade group distribution between 1.5 T and 3 T.
RESULTS: In total, 293 patients within PI-RADS category 4, including 152 (mean 66 ± 8y; median PSA 6.4 ng/ml;116 PZ IL) in the 1.5 T group and 141 (mean 65 ± 8y; median PSA 7.2 ng/ml;100 PZ IL) in the 3 T group were included. Overall amount of PCa (66 % vs 71 %; p = 0.346) and portion of upgraded IL (28 % vs 21 %; p = 0.126) did not differ significantly. At 1.5 T PCa detection was higher in upgraded PZ lesions compared to 3 T (23 % vs 14 %; p = 0.048). The amount of upgraded PZ lesions with ISUP grade group 2-5 PCa was significantly higher at 1.5 T versus 3 T (13.8 % vs 4.0 %; p = 0.007). 33 % (11/33; 1.5 T) and 32 % (10/31; 3 T) of the ISUP grade group 1 PCa of the PZ lesions were detected in upgraded lesions (10% of all PZ index lesions, respectively).
CONCLUSION: DCE enabled the detection of a substantial amount of additional clinically significant PCa in prostate mpMRI at 1.5 T. The effect was smaller at 3 T and was accompanied in relation to 1.5 T by higher risk of overdiagnosis due to detection of additional low-risk PCa.
引用
- Ziayee, Schimmöller, Blondin, et al. Impact of dynamic contrast-enhanced MRI in 1.5 T versus 3 T MRI for clinically significant prostate cancer detection. Eur J Radiol. 2022. PMID: 36116141. doi:10.1016/j.ejrad.2022.110520
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。